Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0CA3J
|
||||
| Former ID |
DNCL001786
|
||||
| Drug Name |
GSK568859
|
||||
| Indication | Atherosclerosis [ICD9: 414.0, 440; ICD10:I70] | Discontinued in Phase 1 | [548491] | ||
| Company |
GlaxoSmithKline
|
||||
| Target and Pathway | |||||
| Target(s) | Lipoprotein-associated phospholipase A2 | Target Info | Modulator | [543419] | |
| Pathway Interaction Database | Lissencephaly gene (LIS1) in neuronal migration and development | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.